US Broker Ratings

Claritev Corporation (CTEV) Investor Outlook: Navigating Healthcare Analytics with a 14.37% Potential Upside

Investors eyeing the healthcare sector might find Claritev Corporation (NASDAQ: CTEV) an intriguing opportunity, especially with its significant potential upside of 14.37% based on current analyst projections. As a player..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Potential 229% Upside Amidst Biotech Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, is currently navigating a challenging landscape with a substantial promise for future growth. This San Francisco-based company, dedicated..

Capricor Therapeutics, Inc. (CAPR): A Biotechnology Stock with 219.88% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is capturing investor attention with its potential upside of 219.88% based on current analyst ratings. As a key player in the..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 76% Potential Upside with Strong Buy Ratings

Simulations Plus, Inc. (NASDAQ: SLP), a key player in the healthcare sector, specializes in health information services. With a market cap of approximately $289 million, the company stands out for..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A Closer Look at Its 6.63% Potential Upside

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has been capturing investor attention within the biotechnology sector, with its focus on pioneering treatments for neurodegenerative diseases and endocrine conditions. With a current market..

Geron Corporation (GERN) Stock Analysis: Unveiling a 174% Upside Potential in the Biotech Sector

Geron Corporation (NASDAQ: GERN) is capturing the attention of investors with its promising growth potential in the biotechnology sector. Known for its innovative approach to oncology therapeutics, Geron is making..

Taysha Gene Therapies (TSHA) Stock Analysis: Unraveling the 167% Upside Potential

Taysha Gene Therapies, Inc. (TSHA) is making waves in the biotechnology sector with its ambitious focus on developing adeno-associated virus-based gene therapies aimed at treating monogenic diseases of the central..

Talkspace, Inc. (TALK) Stock Analysis: A Healthcare Innovator with an 84.62% Upside Potential

Talkspace, Inc. (NASDAQ: TALK), a burgeoning player in the healthcare sector, is captivating the attention of investors with its innovative approach to mental health services and a substantial potential upside..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a 13.86% Upside Potential Amidst Healthcare Innovation

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector under the Diagnostics & Research industry, is capturing investor attention with its potential upside of 13.86%, as reflected..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unveiling a Potential 229% Upside in the Biotech Sector

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology industry, is capturing attention with its impressive potential upside of 229.04%, according to analyst ratings. Based in Brisbane,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Challenges with Growth in Animal Health Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a notable player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic products. Operating in key..

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Potential 45.94% Upside in the Biotech Sector

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline and strategic market positioning. With its focus on developing novel..

SI-BONE, Inc. (SIBN) Stock Analysis: Robust Revenue Growth and Significant Upside Potential for Investors

SI-BONE, Inc. (NASDAQ: SIBN), a notable player in the healthcare sector specializing in medical devices, is attracting significant investor interest. Based in Santa Clara, California, SI-BONE focuses on innovative solutions..

RxSight, Inc. (RXST) Stock Report: Navigating the Medical Device Market with a Unique Edge

RxSight, Inc. (RXST), a company at the forefront of the medical device industry, is making headlines with its innovative approach to cataract surgery. RXST, traded on the U.S. exchanges, specializes..

Syndax Pharmaceuticals, Inc. (SNDX) Investor Outlook: Significant 129% Potential Upside with Innovative Cancer Treatments

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a promising player in the biotechnology sector, has captured the attention of investors with its impressive portfolio of cancer therapies and a remarkable potential upside..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a Promising 111% Potential Upside

Investors watching the biopharmaceutical sector may want to take a closer look at Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage company that has been capturing attention with its innovative approach..

AMN Healthcare Services Inc (AMN): Investor Outlook with a 5.49% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the U.S. healthcare staffing industry, presents a mixed bag of opportunities and challenges for investors. With its current market capitalization..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a 24.66% Potential Upside in Biotech

LENZ Therapeutics, Inc. (NASDAQ: LENZ) is capturing investor attention in the biotechnology sector, thanks to its promising pipeline and significant potential upside. As a biopharmaceutical company headquartered in Solana Beach,..

Beta Bionics, Inc. (BBNX) Stock Analysis: Navigating the Ups and Downs with a 52-Week High

Beta Bionics, Inc. (NASDAQ: BBNX), a trailblazer in the healthcare sector, is making waves in the medical devices industry with its innovative solutions targeting diabetes management. At the heart of..

HealthStream, Inc. (HSTM) Stock Analysis: Navigating a 16.36% Potential Upside in the Healthcare SaaS Arena

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services industry, is catching the eye of investors keen on capitalizing on the technological evolution within healthcare. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds